Background pattern

Medicines with TAPENTADOL FOSFATO in Spain

Filters
P

Pagrentil retard 200 mg comprimidos de liberaciÓn prolongada efg

Dosage form: Prolonged‑release tablet, 306.27 mg
Active substance: TAPENTADOL FOSFATO
Manufacturer: Sandoz Farmaceutica S.A.
Prescription required

Pagrentil retard 25 mg comprimidos de liberaciÓn prolongada efg

Dosage form: Prolonged‑release tablet, 38.28 mg
Active substance: TAPENTADOL FOSFATO
Manufacturer: Sandoz Farmaceutica S.A.
Prescription required

Pagrentil retard 250 mg comprimidos de liberaciÓn prolongada efg

Dosage form: Prolonged‑release tablet, 382.84 mg
Active substance: TAPENTADOL FOSFATO
Manufacturer: Sandoz Farmaceutica S.A.
Prescription required

Pagrentil retard 50 mg comprimidos de liberaciÓn prolongada efg

Dosage form: Prolonged‑release tablet, 76.57 mg
Active substance: TAPENTADOL FOSFATO
Manufacturer: Sandoz Farmaceutica S.A.
Prescription required

Pagrentil retard 100 mg comprimidos de liberaciÓn prolongada efg

Dosage form: Prolonged‑release tablet, 153.13 mg
Active substance: TAPENTADOL FOSFATO
Manufacturer: Sandoz Farmaceutica S.A.
Prescription required

Pagrentil retard 150 mg comprimidos de liberaciÓn prolongada efg

Dosage form: Prolonged‑release tablet, 229.70 mg
Active substance: TAPENTADOL FOSFATO
Manufacturer: Sandoz Farmaceutica S.A.
Prescription required

Palgesic retard 100 mg comprimidos de liberaciÓn prolongada efg

Dosage form: Prolonged‑release tablet, 153.13 mg
Active substance: TAPENTADOL FOSFATO
Manufacturer: Kern Pharma S.L.
Prescription required

Palgesic retard 150 mg comprimidos de liberaciÓn prolongada efg

Dosage form: Prolonged‑release tablet, 229.70 mg
Active substance: TAPENTADOL FOSFATO
Manufacturer: Kern Pharma S.L.
Prescription required

Palgesic retard 200 mg comprimidos de liberaciÓn prolongada efg

Dosage form: Prolonged‑release tablet, 306.27 mg
Active substance: TAPENTADOL FOSFATO
Manufacturer: Kern Pharma S.L.
Prescription required

Palgesic retard 25 mg comprimidos de liberaciÓn prolongada efg

Dosage form: Prolonged‑release tablet, 38.28 mg
Active substance: TAPENTADOL FOSFATO
Manufacturer: Kern Pharma S.L.
Prescription required

Palgesic retard 250 mg comprimidos de liberaciÓn prolongada efg

Dosage form: Prolonged‑release tablet, 382.84 mg
Active substance: TAPENTADOL FOSFATO
Manufacturer: Kern Pharma S.L.
Prescription required

Palgesic retard 50 mg comprimidos de liberaciÓn prolongada efg

Dosage form: Prolonged‑release tablet, 76.57 mg
Active substance: TAPENTADOL FOSFATO
Manufacturer: Kern Pharma S.L.
Prescription required

Get updates and exclusive offers

Be the first to know about new services, platform updates, and subscriber-only promos.

Subscribe
Follow us on social media
FacebookInstagram